Drug Trial Radar · NCT05267743
Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease
Last checked: Nov 20, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
218
Actual
Start
Feb 16, 2021
Primary completion
May 25, 2022
Study completion May 25, 2022
Sponsor
- Lead sponsor
- HK inno.N CorporationIndustry
- Sponsor type
- Industry
- First posted
- Mar 4, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the efficacy and safety of Tegoprazan 50mg, compared to Lansoprazole 30mg in patients with healed erosive reflux disease confirmed by endoscopy following oral administration once daily(QD) of 2 weeks or 4 weeks.
Conditions
- Erosive Reflux Disease
Interventions
Tegoprazan 50mg QDDrug
Tegoprazan 50mg tablets will be orally administered, once daily, for up to 2 weeks or 4 weeks.
Lansoprazole 30mg QDDrug
Lansoprazole 30mg tablets will be orally administered, once daily, for up to 2 weeks or 4 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 4 weeks cumulative ERD healing rate(%)Time frame: 4 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Wonkwang University Hospital
Iksan, Muwang-ro 895, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.